| Clinical data | |
|---|---|
| Other names | Dimepropion; Dimethylcathinone; Dimethylpropion; N,N-Dimethylcathinone; Rakefet |
| Routes of administration | Oral |
| Drug class | Stimulant; Appetite suppressant; Norepinephrine–dopamine releasing agent |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.035.788 |
| Chemical and physical data | |
| Formula | C11H15NO |
| Molar mass | 177.247 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Metamfepramone (INNTooltip International Nonproprietary Name; also known as dimepropion (BANTooltip British Approved Name), dimethylcathinone, and dimethylpropion) is a stimulant drug of the phenethylamine, and cathinone families. Dimethylcathinone was evaluated as an appetite suppressant and for the treatment of hypotension, but was never widely marketed. It was used as a recreational drug in Israel under the name rakefet, but was made illegal in 2006.
Metamfepramone is metabolized to produce N-methylpseudoephedrine and methcathinone. It has also been found to be about 1.6 times less potent than methcathinone, making it roughly equipotent to cathinone itself.
A notable analogue of metamfepramone is dimethylamphetamine (N,N-dimethylamphetamine).
In the United States, metamfepramone is considered a Schedule I controlled substance as a positional isomer of mephedrone.
| Phenethylamines |
| ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amphetamines |
| ||||||||||||||||
| Phentermines |
| ||||||||||||||||
| Cathinones |
| ||||||||||||||||
| Phenylisobutylamines (and further-extended) |
| ||||||||||||||||
| Catecholamines (and close relatives) |
| ||||||||||||||||
| Cyclized phenethylamines |
| ||||||||||||||||
| Related compounds |
| ||||||||||||||||